REGENXBIO Inc. (RGNX) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome, everyone, to the third quarter 2025 Regenexx Bio earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during this session, please press star 11 on your telephone and wait for your name to be announced. Please limit yourself to one question and one follow-up, And if you have additional questions, please return to the queue. And to withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. At this time, I'd like to turn the conference over to Patrick Christmas, Chief Legal Officer of Regenexx Bio. Please go ahead. Good morning, and thank you for joining us today. Earlier this morning, Regenexx Bio released financial and operating results for the third quarter ended September 30th, 2025. The press release is available on our website at www.regenexxbio.com. Today's conference call will include forward-looking statements regarding our financial outlook in addition to regulatory and product development plans. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted. and can be identified by words such as expect, plan, will, may, anticipate, believe, should, intend, and other words of similar meaning. Any such forward-looking statements are not guarantees of future performance and involve certain risks and uncertainties. These risks are described in the risk factors and the management's discussion and analysis section of RegenicBio's annual report on Form 10-K for the full year ended December 31st, 2024. and comparable risk factor sections of Regenexx BIO's quarterly reports on Form 10-Q, which are on file with...